AIMS: A diet with modified components, such as a ketogenic low-carbohydrate (LC) diet, potentially extends longevity and healthspan. However, how an LC diet impacts on cardiac pathology during haemodynamic stress remains elusive. This study evaluated the effects of an LC diet high in either fat (Fat-LC) or protein (Pro-LC) in a mouse model of chronic hypertensive cardiac remodelling. METHODS AND RESULTS: Wild-type mice were subjected to transverse aortic constriction, followed by feeding with the Fat-LC, the Pro-LC, or a high-carbohydrate control diet. After 4 weeks, echocardiographic, haemodynamic, histological, and biochemical analyses were performed. LC diet consumption after pressure overload inhibited the development of pathological hypertrophy and systolic dysfunction compared to the control diet. An anti-hypertrophic serine/threonine kinase, GSK-3β, was re-activated by both LC diets; however, the Fat-LC, but not the Pro-LC, diet exerted cardioprotection in GSK-3β cardiac-specific knockout mice. β-hydroxybutyrate, a major ketone body in mammals, was increased in the hearts of mice fed the Fat-LC, but not the Pro-LC, diet. In cardiomyocytes, ketone body supplementation inhibited phenylephrine-induced hypertrophy, in part by suppressing mTOR signalling. CONCLUSION: Strict carbohydrate restriction suppresses pathological cardiac growth and heart failure after pressure overload through distinct anti-hypertrophic mechanisms elicited by supplemented macronutrients. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: A diet with modified components, such as a ketogenic low-carbohydrate (LC) diet, potentially extends longevity and healthspan. However, how an LC diet impacts on cardiac pathology during haemodynamic stress remains elusive. This study evaluated the effects of an LC diet high in either fat (Fat-LC) or protein (Pro-LC) in a mouse model of chronic hypertensive cardiac remodelling. METHODS AND RESULTS: Wild-type mice were subjected to transverse aortic constriction, followed by feeding with the Fat-LC, the Pro-LC, or a high-carbohydrate control diet. After 4 weeks, echocardiographic, haemodynamic, histological, and biochemical analyses were performed. LC diet consumption after pressure overload inhibited the development of pathological hypertrophy and systolic dysfunction compared to the control diet. An anti-hypertrophic serine/threonine kinase, GSK-3β, was re-activated by both LC diets; however, the Fat-LC, but not the Pro-LC, diet exerted cardioprotection in GSK-3β cardiac-specific knockout mice. β-hydroxybutyrate, a major ketone body in mammals, was increased in the hearts of mice fed the Fat-LC, but not the Pro-LC, diet. In cardiomyocytes, ketone body supplementation inhibited phenylephrine-induced hypertrophy, in part by suppressing mTOR signalling. CONCLUSION: Strict carbohydrate restriction suppresses pathological cardiac growth and heart failure after pressure overload through distinct anti-hypertrophic mechanisms elicited by supplemented macronutrients. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Megan N Roberts; Marita A Wallace; Alexey A Tomilov; Zeyu Zhou; George R Marcotte; Dianna Tran; Gabriella Perez; Elena Gutierrez-Casado; Shinichiro Koike; Trina A Knotts; Denise M Imai; Stephen M Griffey; Kyoungmi Kim; Kevork Hagopian; Marissa Z McMackin; Fawaz G Haj; Keith Baar; Gino A Cortopassi; Jon J Ramsey; Jose Alberto Lopez-Dominguez Journal: Cell Metab Date: 2017-09-05 Impact factor: 27.287
Authors: Adam M Bernstein; Qi Sun; Frank B Hu; Meir J Stampfer; JoAnn E Manson; Walter C Willett Journal: Circulation Date: 2010-08-16 Impact factor: 29.690
Authors: Rogerio F Ribeiro; Erinne R Dabkowski; Kelly A O'Connell; Wenhong Xu; Tatiana de Fatima Galvao; Peter A Hecker; Kadambari C Shekar; Ivanita Stefanon; William C Stanley Journal: Appl Physiol Nutr Metab Date: 2013-09-11 Impact factor: 2.665
Authors: Yun-Hee Youm; Kim Y Nguyen; Ryan W Grant; Emily L Goldberg; Monica Bodogai; Dongin Kim; Dominic D'Agostino; Noah Planavsky; Christopher Lupfer; Thirumala D Kanneganti; Seokwon Kang; Tamas L Horvath; Tarek M Fahmy; Peter A Crawford; Arya Biragyn; Emad Alnemri; Vishwa Deep Dixit Journal: Nat Med Date: 2015-02-16 Impact factor: 53.440
Authors: Rebecca C Schugar; Ashley R Moll; D André d'Avignon; Carla J Weinheimer; Attila Kovacs; Peter A Crawford Journal: Mol Metab Date: 2014-08-13 Impact factor: 7.422
Authors: David Ma; Amy C Wang; Ishita Parikh; Stefan J Green; Jared D Hoffman; George Chlipala; M Paul Murphy; Brent S Sokola; Björn Bauer; Anika M S Hartz; Ai-Ling Lin Journal: Sci Rep Date: 2018-04-27 Impact factor: 4.379
Authors: Roni Nielsen; Niels Møller; Lars C Gormsen; Lars Poulsen Tolbod; Nils Henrik Hansson; Jens Sorensen; Hendrik Johannes Harms; Jørgen Frøkiær; Hans Eiskjaer; Nichlas Riise Jespersen; Søren Mellemkjaer; Thomas Ravn Lassen; Kasper Pryds; Hans Erik Bøtker; Henrik Wiggers Journal: Circulation Date: 2019-04-30 Impact factor: 29.690